isrg stock price: Intuitive Surgical overview
ISRG (Intuitive Surgical, Inc.) — Stock price
isrg stock price refers to the Nasdaq-listed common shares of Intuitive Surgical, Inc., maker of the da Vinci and Ion robotic systems. This article explains how to follow the isrg stock price in real time, what the main price drivers are, key financial and market metrics, recent material news (including Q4 results reported in January 2026), and practical tracking and trading guidance. Readers will get an investor‑friendly primer on market data, corporate actions, analyst sentiment, and risks — and where to check live quotes.
Company overview
Intuitive Surgical, Inc. is a U.S.-headquartered medical-robotics company best known for the da Vinci surgical system family and the Ion endoluminal robotic platform. Founded in 1995 and based in Sunnyvale, California, Intuitive designs, manufactures, and services robotic platforms, instruments and accessories, and data services that assist surgeons and hospitals in minimally invasive procedures. The company’s products and procedure volumes are central to the isrg stock price and valuation because revenue growth and margins depend on system sales, consumable instrument usage per procedure, and recurring service and software revenue.
Ticker and exchange information
- Ticker symbol: ISRG
- Primary exchange: NASDAQ (U.S.)
- Trading currency: U.S. dollars (USD)
- Regular trading hours: 09:30–16:00 ET (typical U.S. equity hours)
- Pre-market and after-hours trading: available for many brokers and data providers; quotes may differ from regular‑session prices and are often displayed as extended-hours or pre‑market/after‑market prices.
Note: Many public data portals show delayed quotes by default (often 15–20 minutes); if you need real‑time accuracy, use a live feed from your broker or a real‑time market data provider.
Current market price and key realtime metrics
When people ask about the isrg stock price they generally mean the last trade price in the market. Finance portals and brokers typically display a set of realtime or near‑realtime metrics that help contextualize that price:
- Last (trade) price — most recent executed trade.
- Change and percent change — difference vs. prior close.
- Bid and ask — highest buy and lowest sell quotes at a point in time.
- Volume — shares traded during the session (intraday) and average daily volume historically.
- Intraday range — low and high during the current trading session.
- 52‑week range — highest and lowest prices over the past 52 weeks.
- Market capitalization — last price × shares outstanding (time‑sensitive).
Common providers for these metrics include major portals such as Yahoo Finance, Google Finance, MarketWatch, and the Nasdaq data page. Keep in mind that the isrg stock price and these metrics change continuously during trading hours and may be displayed with delays on free sites.
As of Jan 23, 2026, according to Benzinga and Barchart reporting, Intuitive Surgical reported a session quote near $526–529 per share following its fourth-quarter results; different snapshots in the same reporting window showed values like $525.13 and $526.86 in public summaries. These time‑stamped figures are illustrative — always check a live feed for up‑to‑the‑second pricing.
Historical price performance
IPO and early trading history
Intuitive Surgical went public in the late 1990s (listed on NASDAQ as ISRG). Its early public performance reflected adoption cycles for surgical robotics and the pace of hospitals purchasing capital equipment. Over the years, the isrg stock price has been shaped by the product adoption curve, regulatory clearances, and recurring procedure growth, shifting from a small‑cap medical-technology name to a large-cap leader in surgical robotics.
Recent multi‑year and 52‑week performance
Investors often review multi‑year charts and the 52‑week high/low to assess trend and volatility. The isrg stock price has historically shown multi‑year appreciation tied to steadily increasing procedure volumes, recurring revenue from instruments and services, and new platform introductions. The 52‑week range is useful for short‑to‑medium term context; for ISRG this range has reflected market reactions to quarterly results, guidance updates, and macro market rotations.
Typical historical measures used by investors:
- Multi‑year price charts (1, 3, 5, 10 years)
- 52‑week high / low and percent from each extreme
- Volatility measures (historical and implied via options)
These measures inform how the current isrg stock price compares with past performance and perceived downside or upside ranges.
All‑time highs/lows and major price milestones
All‑time highs and lows for ISRG are maintained in exchange records and can be verified via the Nasdaq site or historical price databases. Major milestones that materially affected the isrg stock price include product platform launches (e.g., new da Vinci iterations), milestone regulatory clearances, large procedural-adoption inflection points, and significant corporate announcements (M&A, large partnerships, or notable litigation outcomes). For precise all‑time records, consult the Nasdaq historical prices or company investor relations historical data.
Corporate actions affecting share count and price
Corporate actions that change shares outstanding or affect per‑share metrics can influence the isrg stock price in headline or structural ways. Typical items include:
- Stock splits (forward splits) — increase shares outstanding while proportionally reducing price per share.
- Reverse splits — reduce shares outstanding while increasing the nominal share price.
- Secondary offerings or follow‑on sales — add supply if the company issues new shares for capital, which can create downward pressure.
- Share repurchases (buybacks) — reduce shares outstanding and can be supportive for per‑share metrics and the isrg stock price.
Official records of corporate actions are available in SEC filings (e.g., 8‑K, S‑3 registration statements) and the company’s investor relations announcements. When tracking the isrg stock price historically, adjust per‑share figures for splits or other capital actions to compare consistently.
Key financials and valuation metrics
The isrg stock price reflects investors’ collective view on the company’s future cash flows and growth prospects. Important fundamental metrics to monitor include:
- Revenue and revenue growth (quarterly and trailing‑12‑months)
- Net income and adjusted earnings (EPS)
- EBITDA and operating margin
- Gross profit margin (a key metric for a product + consumables model)
- Cash, short‑term investments, and balance‑sheet strength
- Shares outstanding and market capitalization
- Valuation multiples (P/E ratio, EV/EBITDA)
As of the company’s Q4 reporting window in January 2026, Intuitive Surgical reported Q4 revenue of approximately $2.87 billion and adjusted EPS of $2.53, beating some analyst estimates. The company guided to full‑year 2026 procedure growth of approximately 13%–15% and expected gross profit margin near 67%–68% (the guidance window reflects management’s forward view). These time‑stamped metrics (Q4 revenue $2.87B; Q4 adjusted EPS $2.53; 2026 procedure guidance 13%–15%) were reported in mid‑January 2026 and are relevant when contextualizing the isrg stock price around that event.
Sources for up‑to‑date financials include company quarterly and annual reports (10‑Q, 10‑K), investor relations presentations, and aggregated snapshots on major finance portals.
Analyst coverage and price targets
Analyst ratings and price targets are widely followed because they influence sentiment and may move the isrg stock price when published. Ratings are typically categorized as Buy/Outperform, Hold/In‑Line, and Sell/Underperform, and platforms aggregate the distribution and consensus target.
Following the January 2026 quarter, several analysts adjusted targets:
- Bernstein (Lee Hambright) maintained an Outperform rating and raised the price target from $740 to $750.
- Evercore ISI (Vijay Kumar) maintained an In‑Line rating but lowered the price target from $580 to $550.
- Ryan Zimmerman (BTIG) reiterated a Buy rating with a $616 price target after the Q4 results.
As of Jan 23, 2026, multiple outlets reported analyst movement and commentary following Q4; these shifts can create short‑term momentum in the isrg stock price. Aggregated analyst consensus and target ranges are available on major finance portals, which show the current mean, high, and low price targets and the split in analyst recommendations.
News, events, and factors driving the stock price
The isrg stock price reacts to company‑specific developments, industry shifts, macro factors, and market structure. Key moving categories include:
Earnings releases and guidance
Quarterly results, revenue and EPS beats or misses, and management guidance are primary short‑term drivers. For example, Intuitive’s Q4 report (reported after markets closed in mid‑January 2026) showed revenue of about $2.87 billion and adjusted EPS of $2.53, beating some street estimates; management’s measured guidance for 2026 procedure growth (13%–15%) and margin outlook influenced investor expectations and the isrg stock price in extended trading.
Earnings surprises (positive or negative) tend to increase intraday volatility and can shift the trajectory of the isrg stock price for days following the print.
Product and regulatory developments
New product launches, incremental improvements to the da Vinci platform, broader adoption of Ion, imaging or software launches, and regulatory clearances materially affect the isrg stock price. Conversely, device recalls, adverse regulatory actions, or missed clinical endpoints can depress pricing and sentiment for extended periods.
Industry trends and competition
Adoption of robotic‑assisted surgery (RAS), hospital capital budgets, reimbursement policies, and competition from legacy medical device firms or new entrants affect long‑term growth expectations. Macro health‑care spending trends and procedure volumes are foundational for the isrg stock price.
Other market drivers include macroeconomic sentiment (which can compress high multiple growth stocks), interest rate moves, and sector rotations; for example, broader market movements on the day of earnings can amplify ISRG’s price move.
Major shareholders and insider activity
Institutional ownership typically represents a large portion of free‑float shares for ISRG. Major public funds, mutual funds, and active managers often hold shares; filings such as SEC Form 13F (quarterly institutional holdings), proxy statements, and beneficial ownership disclosures identify large holders. Insider transactions (Form 4 filings) show executive or director purchases and sales; while insider buying is often viewed positively by some investors, insider selling can be neutral or routine (e.g., planned sales or diversification).
For the most recent ownership snapshots and insider activity, consult the company’s proxy and public filings alongside aggregated equity data on financial portals. Large, stable institutional holders can affect the isrg stock price by adding liquidity and a long‑term base of holders, while any sudden changes in ownership composition may be notable.
Trading data and market microstructure
Key trading and liquidity considerations for ISRG include average daily volume, intraday liquidity, and bid‑ask spreads. ISRG is generally a well‑traded large‑cap name with relatively tight spreads during regular hours and robust options activity that reflects investor hedging and directional views.
Extended‑hours (pre/post‑market) quotes for the isrg stock price can differ from regular session levels due to lower liquidity and fewer participants; larger orders in extended hours may move prices more than during the open market. Data latency also matters: many websites show delayed quotes, so active traders should use broker feeds that provide real‑time data.
Options volume and open interest are additional indicators of market sentiment; spikes in implied volatility often accompany earnings events and may affect perceived risk in the isrg stock price.
Risks and considerations for investors
This section is factual and not investment advice. Key risks that have historically affected or could affect the isrg stock price include:
- Execution and adoption risk: slower-than-expected adoption of new platforms or slower hospital purchasing cycles.
- Regulatory and legal risk: adverse FDA actions, safety findings, or product recalls.
- Competitive pressure: entrants offering alternative robotic or imaging technologies.
- Dependence on procedure volumes: procedure growth drives recurring consumable revenue; declines in procedure counts can reduce revenue.
- Hospital capital spending cycles and reimbursement changes: macro and health‑system budgets influence purchases.
- Macroeconomic sensitivity: broader market sell‑offs, rate changes, or sector rotation can affect multiples and the isrg stock price.
Readers should verify facts and consult qualified advisors for personalized decisions.
How to track and trade ISRG
Where to get price quotes and research:
- Company investor relations pages and SEC filings for official releases and financial statements (primary sources).
- Major finance portals for quick snapshots and consensus metrics (Yahoo Finance, Google Finance, MarketWatch, Nasdaq pages) — note possible quote delays.
- Brokerage platforms for real‑time quotes, execution, and detailed order entry (for trading). Bitget is recommended here for trading access and execution for users seeking a regulated brokerage-style interface (please check local availability and account requirements).
- APIs and professional data feeds for programmatic access to real‑time pricing and historical data.
General trading considerations:
- Confirm whether your price feed is real‑time or delayed.
- Understand trading hours (regular vs extended sessions) and the liquidity differences in each.
- Check commissions, settlement rules, margin requirements, and tax implications with your broker. Bitget provides market access, but platform rules and fees vary by jurisdiction.
Note: ISRG is an equity (not a cryptocurrency); if you use Web3 tooling for portfolio management, prefer Bitget Wallet for custody options where supported.
Notable historical events (timeline)
Below is a concise timeline of selected events that materially affected the isrg stock price (dates are illustrative; verify exact dates in official filings and press releases):
- 1997–1999: IPO and transition to public markets — foundational listing as ISRG on NASDAQ.
- Multiple years: Launches of successive da Vinci platform generations — each major upgrade coincided with investor focus on growth runway.
- 2019–2021: Accelerated global adoption and recurring instrument revenue growth — helped support multi‑year share appreciation.
- Mid‑2020s: Introduction and early adoption of the Ion platform (endoluminal robotic system) — viewed as a new TAM expansion and affected expectations for mid‑term growth.
- Jan 2026: Q4 results reported after the close — revenue ~$2.87B and adjusted EPS $2.53, with 2026 procedure guidance of ~13%–15% and gross margin guidance of 67%–68%; multiple analysts updated price targets and ratings, causing modest moves in the isrg stock price in extended and following sessions.
For a complete, validated timeline with exact filing links and dates, review the company’s investor relations news archive and SEC filings.
See also
- Surgical robotics
- Medical device industry overview
- Market capitalization and P/E ratio (valuation basics)
- Comparable tickers and peers in surgical and medical devices
References
- Intuitive Surgical investor relations and SEC filings (company press releases, 10‑K and 10‑Q statements) — for official financials and corporate actions.
- Market data and price snapshots from Yahoo Finance, Google Finance, MarketWatch, Nasdaq — for current and historical price metrics.
- News reporting (Jan 2026): Benzinga, Barchart and related coverage summarizing Q4 results and analyst reactions. As of Jan 23, 2026, Benzinga and Barchart reported the Q4 figures and price moves; analyst target changes were reported in the same news cycle.
All numeric figures and price points in this article are time‑sensitive. Always verify the latest isrg stock price and financial data on primary sources or via your brokerage.
External resources
- Intuitive Surgical investor relations (company announcements and filings)
- SEC EDGAR (official filings and disclosures)
- Market data pages (Yahoo Finance ISRG, Google Finance ISRG, MarketWatch ISRG, Nasdaq ISRG) for live quotes and historical charts
How the recent Q4 2025 / early‑2026 reporting affected the isrg stock price (time‑stamped summary)
As of Jan 23, 2026, according to Benzinga and Barchart reporting, Intuitive Surgical reported fourth‑quarter revenue of about $2.87 billion and adjusted earnings of $2.53 per share, both above some near‑term expectations. The company provided measured guidance for 2026 procedure growth (approximately 13%–15%) and expected gross profit margin in a 67%–68% range. Following the results and guidance, analysts updated price targets: Bernstein raised its target to $750, Evercore lowered its target to $550 while maintaining an In‑Line rating, and other firms reiterated or revised ratings and targets. Market snapshots in that window showed the isrg stock price between roughly $525 and $529 in different feeds and at different times around the release. These developments created near‑term trading interest and were reflected in intraday moves and pre/post‑market quotes.
Practical checklist to monitor the isrg stock price
- Confirm whether displayed quotes are real‑time or delayed.
- Check the company’s investor relations for official press releases and the exact time stamp of earnings releases or guidance updates.
- Review analyst notes and consensus targets from multiple providers to understand sentiment breadth (note date and author when reviewing).
- Watch options implied volatility and volume around earnings to assess market expectations for post‑earnings moves.
- Monitor procedure volume commentary and product adoption metrics during calls and presentations — these items often drive forward growth assumptions embedded in the isrg stock price.
Final notes and guidance
This article described how to find and interpret the isrg stock price (real‑time and historical), what moves it, and how to track it. It used time‑stamped Q4 2025 / Jan 2026 reporting highlights as an example of how earnings and guidance influence price and analyst reaction. If you wish to trade ISRG, choose a regulated broker and confirm data feeds are real‑time; Bitget is presented here as a recommended trading platform where available. For custody or wallet needs related to Web3 tools, consider Bitget Wallet.
Remember: the isrg stock price is dynamic and subject to company performance, analysts’ revisions, macro factors, and market microstructure. Verify all numeric figures from original filings and live data providers before acting.
Further exploration: Explore Intuitive Surgical’s investor relations materials for full reports and listen to recent earnings calls for management commentary. Check real‑time quotes on your broker (e.g., Bitget) for execution and the most up‑to‑date pricing.
